Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Petition for writ of certiorari in case brought by Billye Jean Martin and Libra Salazar against the firm in Texas is denied by Supreme Court Jan. 7, upholding U.S. Court of Appeals for the Fifth Circuit findings that Medtronic's compliance with FDA's premarket approval process preempts state tort law claims. The lawsuit alleging a Medtronic pacemaker used a defective ventricular lead was based on claims of deficiencies in safety and effectiveness of design, manufacturing processes, warnings and labeling...
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.